QualPharma December 2020

NEWS REVIEWS
Ayurvedic doctor’s authorized
to do surgery
PM Modi Warns Of Possible Side-Effects
Government brought a notification that will allow Ayurvedic
doctor to be trained and legally allowed to perform
a variety of surgery which include ENT, ophthalmology,
ortho and dental procedure.
Centre council of Indian medicine president said the surgery
have been going in Ayurveda institute for approx 25
years. The recent notification will provide clarity and legality
The notification listed the procedure that will be included
in the PG training of Ayurvedic Doctors by amending the
Indian Medicine centre council (PG Ayurvedic Education)
regulations 2016. During the course, post graduate scholars
of Shalya Tantra (General surgery) and Shalakya Tantra
(Surgeries of Ear, nose, throat, head and eye) will be practically
trained to perform various surgical procedures independently.
General surgical procedure included amputation of gangarene,
skin grafting, laparotomy (opening up of the abdomen)
and many advanced gastro-intestinal surgeries.
Prime Minister Narendra Modi
warned on Tuesday that any
COVID-19 vaccine could lead to
side-effects in some people, as
even popular medicines do, and
that the government would only
go by science in finalising one
for the country.
PM Modi said both speed and
safety were equally important in
launching a vaccine, but that,
once established scientific processes
had determined the right
path, India would follow it.
"Even medicines popular for 20
years and used by hundreds of
thousands of people lead to
reactions in some, even today,"
PM Modi said in a video conference
with the chief ministers.
"It's possible with vaccines too.
Any decision on them should
only be weighed on a scientific
scale. Whatever vaccine makes
it through the world's certified
processes, we will have to accept
them and move ahead."
The Serum Institute of India
said it would first focus on supplying
its home market in the
next few months.
The other experimental vaccines
on trial in India are the
government and Bharat Biotech's
COVAXIN; Russia's Sputnik-V;
Zydus Cadila's ZyCoV-D
and lastly one that Biological E.
Ltd is developing with Baylor
College of Medicine and Dynavax
Technologies Corp.
The Intelligent regulatory solution
We ensure eCTD, US DMF (for API/ Excipients), European DMF, Canada DMF, CEP ( Ph. Eur), cGMP Approval
(WHO/EU/FDA), 510(k) for Medical Devices , ISO 15378 & 13485
www.perfectdossier.com
QualPharma *Dec 2020* , Vol.3 ISSUE 12